Global Fabry Disease Treatment Market Size study & Forecast, by Treatment, Route of Administration, Distribution Channel, and Regional Analysis, 2022-2029

Description

List of Tables

Global Fabry Disease Treatment Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 6.8% over the forecast period 2022-2029. Lysosomal storage disorders are a class of diseases that includes Fabry disease. It is an uncommon hereditary condition that can impact the kidneys, heart, skin, and other organs. The patient has increasing organ failure as a result of a deficiency in the enzyme alpha-galactosidase. The fundamental cause of Fabry disease is the abnormal buildup of globotriaosylceramide, a specific type of fatty substance. Factors contributing towards the market growth include expanding base of patients suffering from Fabry disease and the growing popularity of substrate reduction therapies and gene therapies.

The National Fabry Disease Foundation (NFDF) states that "April" is recognized as Fabry Disease Awareness Month each year. Additionally, Fabry Australia, Fabry International Network (FIN), and MPS Society in the UK are among the organizations that formally mark April as Fabry Disease Awareness Month. Additionally, these groups increase Fabry disease awareness during the month of April. This includes educating members of the public, clients, caregivers, and medical specialists. The market is also expanding because of an increase in Fabry disease research and development. Fabry disease research and development are continuously funded by organizations across the globe. For instance, the Smart functional GLA-nano formulation for the Fabry disease study was supported by the Horizon 2020 Framework Programme (H2020) (Smart-4-Fabry). The project was initiated in 2017, and its most recent workshop was held in February 2021. However, a lack of diagnostic resources in emerging country's market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Fabry Disease Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is expected to dominate the overall market share owing to high usage of the brand Fabrazyme and widespread of awareness related to early diagnosis of Fabry disease. However, Asia Pacific is projected to be the fastest growing region due to rise in the healthcare expenditure and growth in the Fabry disease drug market.

Major market players included in this report are:

Amicus Therapeutics, Inc

Sanofi (Genzyme Corporation)

Protalix BioTherapeutics

JCR Pharmaceuticals Co., Ltd.

Takeda Pharmaceutical Company Limited

Freeline Therapeutics Holdings PLC

ISU ABXIS

Chiesi Farmaceutici S.p.A.

BIOSIDUS

Avrobio, Inc.

Recent Developments in the Market:

Chiesi Farmaceutici S.p.A. announced the launch of a new business unit called Chiesi Global Rare Diseases in February 2020. Additionally, the aim of this newly established business unit is to perform cutting-edge research and develop innovative products for the treatment of uncommon and ultra-rare diseases, including lysosomal storage disorders such as Fabry disease.
Micus Therapeutics is becoming a major participant in the field of rare diseases with the introduction of Galafold, the first oral therapy for Fabry disease. Due to the expanding popularity of substrate reduction treatments and gene therapies in the market and the probable introduction of their respective pipeline medicines, lucerastat and AVR-RD-01, Idorsia and Avrobio are also anticipated to command a significant market share.

Global Fabry Disease Treatment Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Treatment, Route of Administration, Distribution Channel, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study.

The report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment:

Enzyme Replacement Therapy

Oral Chaperone Therapy

Other Treatments

By Route of Administration:

Oral Route

Intravenous Route

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Region:

North America

U.S.

Canada

Europe

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
- 1.2.1. Fabry Disease Treatment Market, by Region, 2019-2029 (USD Billion)
- 1.2.2. Fabry Disease Treatment Market, by Treatment, 2019-2029 (USD Billion)
- 1.2.3. Fabry Disease Treatment Market, by Route of Administration, 2019-2029 (USD Billion)
- 1.2.4. Fabry Disease Treatment Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Fabry Disease Treatment Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Fabry Disease Treatment Market Dynamics

3.1. Fabry Disease Treatment Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
  - 3.1.1.1. Rising awareness regarding Fabry disease
  - 3.1.1.2. Growing popularity of substrate reduction therapies and gene therapies
- 3.1.2. Market Challenges
  - 3.1.2.1. Lack of diagnostic resources in emerging countries
- 3.1.3. Market Opportunities
  - 3.1.3.1. Favourable governmental healthcare policies
  - 3.1.3.2. Rise in research and development related to Fabry disease treatment

Chapter 4. Global Fabry Disease Treatment Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Fabry Disease Treatment Market, by Treatment

6.1. Market Snapshot
6.2. Global Fabry Disease Treatment Market by Treatment, Performance - Potential Analysis
6.3. Global Fabry Disease Treatment Market Estimates & Forecasts by Treatment 2019-2029 (USD Billion)
6.4. Fabry Disease Treatment Market, Sub Segment Analysis
- 6.4.1. Enzyme Replacement Therapy
- 6.4.2. Oral Chaperone Therapy
- 6.4.3. Other Treatments

Chapter 7. Global Fabry Disease Treatment Market, by Route of Administration

7.1. Market Snapshot
7.2. Global Fabry Disease Treatment Market by Route of Administration, Performance - Potential Analysis
7.3. Global Fabry Disease Treatment Market Estimates & Forecasts by Route of Administration 2019-2029 (USD Billion)
7.4. Fabry Disease Treatment Market, Sub Segment Analysis
- 7.4.1. Oral Route
- 7.4.2. Intravenous Route

Chapter 8. Global Fabry Disease Treatment Market, by Distribution Channel

8.1. Market Snapshot
8.2. Global Fabry Disease Treatment Market by Distribution Channel, Performance - Potential Analysis
8.3. Global Fabry Disease Treatment Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
8.4. Fabry Disease Treatment Market, Sub Segment Analysis
- 8.4.1. Hospital Pharmacies
- 8.4.2. Retail Pharmacies
- 8.4.3. Online Pharmacies

Chapter 9. Global Fabry Disease Treatment Market, Regional Analysis

9.1. Fabry Disease Treatment Market, Regional Market Snapshot
9.2. North America Fabry Disease Treatment Market
- 9.2.1. U.S. Fabry Disease Treatment Market
  - 9.2.1.1. Treatment breakdown estimates & forecasts, 2019-2029
  - 9.2.1.2. Route of Administration breakdown estimates & forecasts, 2019-2029
  - 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029

Canada Fabry Disease Treatment Market

9.3. Europe Fabry Disease Treatment Market Snapshot
- 9.3.1. U.K. Fabry Disease Treatment Market
- 9.3.2. Germany Fabry Disease Treatment Market
- 9.3.3. France Fabry Disease Treatment Market
- 9.3.4. Spain Fabry Disease Treatment Market
- 9.3.5. Italy Fabry Disease Treatment Market
- 9.3.6. Rest of Europe Fabry Disease Treatment Market
9.4. Asia-Pacific Fabry Disease Treatment Market Snapshot
- 9.4.1. China Fabry Disease Treatment Market
- 9.4.2. India Fabry Disease Treatment Market
- 9.4.3. Japan Fabry Disease Treatment Market
- 9.4.4. Australia Fabry Disease Treatment Market
- 9.4.5. South Korea Fabry Disease Treatment Market
- 9.4.6. Rest of Asia Pacific Fabry Disease Treatment Market
9.5. Latin America Fabry Disease Treatment Market Snapshot
- 9.5.1. Brazil Fabry Disease Treatment Market
- 9.5.2. Mexico Fabry Disease Treatment Market
9.6. Rest of The World Fabry Disease Treatment Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies
10.2. Company Profiles
- 10.2.1. Amicus Therapeutics, Inc
  - 10.2.1.1. Key Information
  - 10.2.1.2. Overview
  - 10.2.1.3. Financial (Subject to Data Availability)
  - 10.2.1.4. Product Summary
  - 10.2.1.5. Recent Developments
- 10.2.2. Sanofi (Genzyme Corporation)
- 10.2.3. Protalix BioTherapeutics
- 10.2.4. JCR Pharmaceuticals Co., Ltd.
- 10.2.5. Takeda Pharmaceutical Company Limited
- 10.2.6. Freeline Therapeutics Holdings PLC
- 10.2.7. ISU ABXIS
- 10.2.8. Chiesi Farmaceutici S.p.A.
- 10.2.9. BIOSIDUS
- 10.2.10. Avrobio, Inc.

Chapter 11. Research Process

11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Fabry Disease Treatment Market, report scope
TABLE 2. Global Fabry Disease Treatment Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Fabry Disease Treatment Market estimates & forecasts by Treatment 2019-2029 (USD Billion)
TABLE 4. Global Fabry Disease Treatment Market estimates & forecasts by Route of Administration 2019-2029 (USD Billion)
TABLE 5. Global Fabry Disease Treatment Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
TABLE 6. Global Fabry Disease Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Fabry Disease Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Fabry Disease Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Fabry Disease Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Fabry Disease Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Fabry Disease Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Fabry Disease Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Fabry Disease Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Fabry Disease Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Fabry Disease Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Fabry Disease Treatment Market
TABLE 71. List of primary sources, used in the study of global Fabry Disease Treatment Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

FIG 1. Global Fabry Disease Treatment Market, research methodology
FIG 2. Global Fabry Disease Treatment Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Fabry Disease Treatment Market, key trends 2021
FIG 5. Global Fabry Disease Treatment Market, growth prospects 2022-2029
FIG 6. Global Fabry Disease Treatment Market, porters 5 force model
FIG 7. Global Fabry Disease Treatment Market, pest analysis
FIG 8. Global Fabry Disease Treatment Market, value chain analysis
FIG 9. Global Fabry Disease Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Fabry Disease Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Fabry Disease Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Fabry Disease Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Fabry Disease Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Fabry Disease Treatment Market, regional snapshot 2019 & 2029
FIG 15. North America Fabry Disease Treatment Market 2019 & 2029 (USD Billion)
FIG 16. Europe Fabry Disease Treatment Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Fabry Disease Treatment Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Fabry Disease Treatment Market 2019 & 2029 (USD Billion)
FIG 19. Global Fabry Disease Treatment Market, company Market share analysis (2021)